A clinical trial of WVE-3972-01 for the treatment of frontotemporal dementia (FTD)

Trial Profile

A clinical trial of WVE-3972-01 for the treatment of frontotemporal dementia (FTD)

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs WVE-3972-01 (Primary)
  • Indications Dementia
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Dec 2017 New trial record
    • 11 Dec 2017 According to a WaVe life Sciences media release, the company intends to initiate this trial in the fourth quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top